Next-generation sequencing for BCR-ABL1 kinase domain mutation testing in patients with chronic myeloid leukemia: a position paper

BCR-ABL1 kinase domain (KD) mutation status is considered to be an important element of clinical decision algorithms for chronic myeloid leukemia (CML) patients who do not achieve an optimal response to tyrosine kinase inhibitors (TKIs). Conventional Sanger sequencing is the method currently recomme...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Hematol Oncol
Main Authors: Soverini, Simona, Abruzzese, Elisabetta, Bocchia, Monica, Bonifacio, Massimiliano, Galimberti, Sara, Gozzini, Antonella, Iurlo, Alessandra, Luciano, Luigiana, Pregno, Patrizia, Rosti, Gianantonio, Saglio, Giuseppe, Stagno, Fabio, Tiribelli, Mario, Vigneri, Paolo, Barosi, Giovanni, Breccia, Massimo
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6894351/
https://ncbi.nlm.nih.gov/pubmed/31801582
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-019-0815-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados